{"id":688705,"date":"2022-09-26T08:22:20","date_gmt":"2022-09-26T12:22:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/"},"modified":"2022-09-26T08:22:20","modified_gmt":"2022-09-26T12:22:20","slug":"erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/","title":{"rendered":"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, Sept.  26, 2022  (GLOBE NEWSWIRE) &#8212; Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS\/MAPK pathway-driven cancers, today announced its participation in the Bank of America Securities Precision Oncology Conference. Jonathan E. Lim, M.D., chairman, CEO, and co-founder, and David M. Chacko, M.D., chief financial officer, will represent Erasca in a virtual fireside chat at 3:40 pm Eastern Time on Monday, October 3, 2022. Drs. Lim and Chacko will also participate in one-on-one investor meetings.<\/p>\n<p>A live webcast of the event will be available online at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JjW9mw6UQDB65eRtQhndTwYavYySJeKzSQut0gHOH-ZGUUU3e5hZBmimFZF1xG6G347StaVUsGT9pjh2p0WiaZyJs72YzB_uPkq4iXRZ58BR2pwY2Hh1sGGyJyDxzfZ93ADsFO7adpV4zK3IV2zW7A4MSGBBuj7v8gKUY40P_iE=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/bofa.veracast.com<\/a>. An archived replay of the event will be available until January 3, 2023, following the webcast at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jSP9bsZnIiCZTyWM7ZAYj5gVFHpmCMiMXwBVQI5NyqO9osalDa6a7AydL6BZMYZMIwL8CUlSKEvOEgAvdg1_8rv5XbD6oMJrCMm-neU766m5ft6lUJ4YT4tZqSicq_ahGJGj7SJi02UR0VApcuGyVj1xNW0tdyv2He5b9pl9SCbX_XJmdWwTZkqbpzC56Dd5DDfMjSUvKhBvgLp4qt8zLr3ThHhJSp9xbUgW-wGeYW4zRYXnTAOnBAalfXFxAFJNX0JXyBW0YQ4u4dHwV3dGE3Infc2YK6R-e3ZUuzs8m6k=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Erasca.com\/events<\/u><\/a>.<\/p>\n<p>\n        <strong>About Erasca<\/strong><br \/>\n        <br \/>At Erasca, our name is our mission: To <u>eras<\/u>e <u>ca<\/u>ncer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS\/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS\/MAPK pathway for the treatment of cancer. We have assembled what we believe to be the deepest RAS\/MAPK pathway-focused pipeline in the industry. We believe our team\u2019s capabilities and experience, further guided by our scientific advisory board which includes the world\u2019s leading experts in the RAS\/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Joyce Allaire<br \/>LifeSci Advisors, LLC<br \/>jallaire@lifesciadvisors.com<\/p>\n<p>Source: Erasca, Inc.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MmY0NzE5NDQtZjRlYy00YzY4LTk1OGItZmQ1ZTM3NzUzZjY5LTUwMDA5ODYzNA==\/tiny\/Erasca-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS\/MAPK pathway-driven cancers, today announced its participation in the Bank of America Securities Precision Oncology Conference. Jonathan E. Lim, M.D., chairman, CEO, and co-founder, and David M. Chacko, M.D., chief financial officer, will represent Erasca in a virtual fireside chat at 3:40 pm Eastern Time on Monday, October 3, 2022. Drs. Lim and Chacko will also participate in one-on-one investor meetings. A live webcast of the event will be available online at https:\/\/bofa.veracast.com. An archived replay of the event will be available until January 3, 2023, following the webcast at Erasca.com\/events. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-688705","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS\/MAPK pathway-driven cancers, today announced its participation in the Bank of America Securities Precision Oncology Conference. Jonathan E. Lim, M.D., chairman, CEO, and co-founder, and David M. Chacko, M.D., chief financial officer, will represent Erasca in a virtual fireside chat at 3:40 pm Eastern Time on Monday, October 3, 2022. Drs. Lim and Chacko will also participate in one-on-one investor meetings. A live webcast of the event will be available online at https:\/\/bofa.veracast.com. An archived replay of the event will be available until January 3, 2023, following the webcast at Erasca.com\/events. About &hellip; Continue reading &quot;Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-26T12:22:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022\",\"datePublished\":\"2022-09-26T12:22:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/\",\"name\":\"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==\",\"datePublished\":\"2022-09-26T12:22:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/","og_locale":"en_US","og_type":"article","og_title":"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk","og_description":"SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS\/MAPK pathway-driven cancers, today announced its participation in the Bank of America Securities Precision Oncology Conference. Jonathan E. Lim, M.D., chairman, CEO, and co-founder, and David M. Chacko, M.D., chief financial officer, will represent Erasca in a virtual fireside chat at 3:40 pm Eastern Time on Monday, October 3, 2022. Drs. Lim and Chacko will also participate in one-on-one investor meetings. A live webcast of the event will be available online at https:\/\/bofa.veracast.com. An archived replay of the event will be available until January 3, 2023, following the webcast at Erasca.com\/events. About &hellip; Continue reading \"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-26T12:22:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022","datePublished":"2022-09-26T12:22:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/","name":"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==","datePublished":"2022-09-26T12:22:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1Mjc1OCM1MTcwMTU2IzUwMDA5ODYzNA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/erasca-to-present-at-the-bank-of-america-securities-precision-oncology-conference-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=688705"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688705\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=688705"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=688705"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=688705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}